Lyondell Chemical Co - Current report filing (8-K)
21 November 2007 - 3:19AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (date of earliest event reported): November 20, 2007
LYONDELL
CHEMICAL COMPANY
(Exact
name of registrant as specified in its charter)
Delaware
(State
or
other jurisdiction of incorporation)
1-10145
(Commission
File Number)
|
95-4160558
(I.R.S.
Employer Identification No.)
|
|
|
1221
McKinney Street, Suite 700, Houston, Texas
(Address
of principal executive offices)
|
77010
(Zip
Code)
|
(713)
652-7200
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01 Other Events
On
November 20, 2007, Lyondell Chemical Company (“Lyondell,”) and its subsidiaries
Equistar Chemicals, LP (“Equistar”) and Equistar Funding Corporation (“Equistar
Funding,” together with Equistar, the “Equistar Issuers”) announced that they
have commenced cash tender offers for an aggregate of approximately $4.01
billion of outstanding debt securities issued by Lyondell and the Equistar
Issuers, as applicable.
The
press
release regarding this matter is being filed with this Current Report on Form
8-K as Exhibit 99.1.
Item
9.01 Financial
Statements and Exhibits
(d) Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
LYONDELL
CHEMICAL COMPANY
By:
/s/
Kerry A. Galvin
Name: Kerry
A. Galvin
Title: Senior
Vice President and
General
Counsel
Date: November
20, 2007
INDEX
TO EXHIBITS
Exhibit
Number
Description
Lyondell (NYSE:LYO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Lyondell (NYSE:LYO)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Lyondell Chemical (New York Stock Exchange): 0 recent articles
More Lyondell Chemical Co News Articles